The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4receptors in rodents
出版年份 2013 全文链接
标题
The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4receptors in rodents
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 169, Issue 8, Pages 1824-1839
出版商
Wiley
发表日期
2013-05-28
DOI
10.1111/bph.12254
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT1A signalling
- (2013) Joanna M. Wierońska et al. PSYCHOPHARMACOLOGY
- Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature
- (2012) Craig W Lindsley et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity
- (2012) S. Lopez et al. NEUROBIOLOGY OF DISEASE
- Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu4 receptor
- (2012) Anna Sławińska et al. NEUROPHARMACOLOGY
- Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia
- (2012) Khaled-Ezaheir Bennouar et al. NEUROPHARMACOLOGY
- DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2/3 receptor stimulation
- (2012) Lena Wischhof et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The GABABreceptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice
- (2011) JM Wierońska et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal models of schizophrenia
- (2011) CA Jones et al. BRITISH JOURNAL OF PHARMACOLOGY
- Guide to Receptors and Channels (GRAC), 5th edition
- (2011) SPH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia
- (2011) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery
- (2011) Bruce J. Melancon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia
- (2011) Joanna M. Wierońska et al. PSYCHOPHARMACOLOGY
- An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction
- (2010) Stephen P. East et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease
- (2010) Susan Duty BRITISH JOURNAL OF PHARMACOLOGY
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat
- (2010) Caitlin A. Jones et al. PSYCHOPHARMACOLOGY
- Active-Site Concentrations of Chemicals - Are They a Better Predictor of Effect than Plasma/Organ/Tissue Concentrations?
- (2009) Margareta Hammarlund-Udenaes BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism
- (2009) Corinne Beurrier et al. FASEB JOURNAL
- Unique Antipsychotic Activities of the Selective Metabotropic Glutamate Receptor 1 Allosteric Antagonist 2-Cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one
- (2009) A. Satow et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
- (2008) P. Jeffrey Conn et al. NATURE REVIEWS DRUG DISCOVERY
- Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents
- (2008) A. Pałucha-Poniewiera et al. NEUROPHARMACOLOGY
- Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
- (2008) P. Jeffrey Conn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice
- (2007) Juliana V. Leite et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search